meRfi®-GM
Tumor-infiltrating lymphocytes (TILs)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Cellular transformation induces phenotypically distinct populations of tumor-infiltrating T cells
CD8+ T cells in tumors predict better outcomes. They are key for Immune Checkpoint Inhibitors (ICIs) Therapy
In addition, ILTCKs are also included
ILTCKs are alfa/beta T cell receptor (TCR)-positive FCER1G-expressing innate T …
References (Sources)
- Bystander CD8 +T cells are abundant and phenotypically distinct in human tumour infiltrates
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironmentReview
- Identifying the source of tumour-infiltrating T cells
- Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing
- Single-cell map of diverse immune phenotypes in the breast tumor microenvironment
- The Immune Contexture in Human Tumors: Impact on Clinical Outcome
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review